NEW TRANSDERMAL VACCINE DELIVERY SYSTEM
新型透皮疫苗输送系统
基本信息
- 批准号:2005808
- 负责人:
- 金额:$ 10万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-09-01 至 1998-08-15
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The objective of the proposed research is to demonstrate the feasibility
of a new transdermal vaccine and/or drug delivery method which combines
the technology of antigen microencapsulation and a novel electroporation
method. The method will allow painless delivery of microspheres through
the stratum comeum (SC) and into the viable epidermis and dermis.
Microencapsulation provides timed release of vaccine antigen, it can
reduce the dose of antigen required and it can stabilize the vaccine,
thereby prolonging its shelf life. Currently there is no developed method
for transdermal delivery of microencapsulated antigens. This research
proposes the development of a new transdermal method for the delivery of
antigen loaded microspheres through the skin. The method will have the
capability of administering both charged and non-charged microspheres. In
Phase I, the new method for transdermal delivery of microspheres
containing Staphylococcal enterotoxin A will be developed and evaluated
both in vitro and in vivo by measuring the immune response to the
enteroxin in mice. In Phase II, the method will be further evaluated for
the delivery of other antigens and/or proteins and a prototype device will
designed.
PROPOSED COMMERCIAL APPLICATION: It is envisaged that the new transdermal
system for vaccine and/or drug delivery will be designed as a disposable
"patch" which will be connected to a portable voltage generator to
administer the vaccine or drug. The new system will be painless,
inexpensive and sanitary and would have enormous applications for vaccine
delivery in Third World countries. Also, the system can be widely used in
disease prevention or cure where timed and controlled release of
pharmaceuticals into body fluids is needed.
提出研究的目的是为了证明可行性
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
G DUNCAN HITCHENS其他文献
G DUNCAN HITCHENS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('G DUNCAN HITCHENS', 18)}}的其他基金
Soluble Peracid Powders for Medical Device Disinfection
用于医疗器械消毒的可溶性过酸粉末
- 批准号:
6645725 - 财政年份:2003
- 资助金额:
$ 10万 - 项目类别:
相似海外基金
ERI: Revealing the Reconfiguration Dynamics of Lipid Bilayer and Its Hydration Structures with Nanoscale Resolution during Electroporation
ERI:以纳米级分辨率揭示电穿孔过程中脂质双层的重构动力学及其水合结构
- 批准号:
2302013 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Standard Grant
Optimization of High Frequency Irreversible Electroporation (H-FIRE) for tumor ablation and immune system activation in pancreatic cancer applications
高频不可逆电穿孔 (H-FIRE) 的优化,用于胰腺癌应用中的肿瘤消融和免疫系统激活
- 批准号:
10659581 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Irreversible Electroporation (IRE) Combined with CD40 Agonism as In Situ Vaccine Therapy for Pancreatic Cancer
不可逆电穿孔 (IRE) 联合 CD40 激动作为胰腺癌原位疫苗治疗
- 批准号:
10718057 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Self-powered disinfection of Viruses and Bacteria in water using Oxidation-assisted electroporation and Tribo-Electric Nanogenerators (VIBO-TENG)
使用氧化辅助电穿孔和摩擦纳米发电机 (VIBO-TENG) 对水中的病毒和细菌进行自供电消毒
- 批准号:
EP/X022730/1 - 财政年份:2023
- 资助金额:
$ 10万 - 项目类别:
Fellowship
Identification of impedance measurement devices, heating hardware, and operating parameters to augment instrumentation for a commercial in vivo electroporation system
识别阻抗测量装置、加热硬件和操作参数,以增强商业体内电穿孔系统的仪器
- 批准号:
10484502 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
开发基于不可逆电穿孔的合理组合以增强癌症免疫疗法对胰腺导管腺癌的活性
- 批准号:
10363932 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Adaptable and scalable electroporation for cellular therapy
用于细胞治疗的适应性和可扩展的电穿孔
- 批准号:
10545845 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
开发基于不可逆电穿孔的合理组合以增强癌症免疫疗法对胰腺导管腺癌的活性
- 批准号:
10559607 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
ex vivo electroporation培養法による歯の運命決定因子の探索
利用离体电穿孔培养法寻找决定牙齿命运的因素
- 批准号:
22K17233 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Academic-Industrial Partnership to Develop Clinical Tools for Algorithmic Irreversible Electroporation of Inoperable Tumors
学术与工业合作开发用于不可手术肿瘤的算法不可逆电穿孔的临床工具
- 批准号:
10504276 - 财政年份:2022
- 资助金额:
$ 10万 - 项目类别: